Cargando…

The acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncSmad7

The histone acetyltransferase p300 (also known as KAT3B) is a general transcriptional coactivator that introduces the H3K27ac mark on enhancers triggering their activation and gene transcription. Genome-wide screenings demonstrated that a large fraction of long non-coding RNAs (lncRNAs) plays a role...

Descripción completa

Detalles Bibliográficos
Autores principales: Maldotti, Mara, Lauria, Andrea, Anselmi, Francesca, Molineris, Ivan, Tamburrini, Annalaura, Meng, Guohua, Polignano, Isabelle Laurence, Scrivano, Mirko Giuseppe, Campestre, Fabiola, Simon, Lisa Marie, Rapelli, Stefania, Morandi, Edoardo, Incarnato, Danny, Oliviero, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934626/
https://www.ncbi.nlm.nih.gov/pubmed/35137201
http://dx.doi.org/10.1093/nar/gkac083
_version_ 1784671885807583232
author Maldotti, Mara
Lauria, Andrea
Anselmi, Francesca
Molineris, Ivan
Tamburrini, Annalaura
Meng, Guohua
Polignano, Isabelle Laurence
Scrivano, Mirko Giuseppe
Campestre, Fabiola
Simon, Lisa Marie
Rapelli, Stefania
Morandi, Edoardo
Incarnato, Danny
Oliviero, Salvatore
author_facet Maldotti, Mara
Lauria, Andrea
Anselmi, Francesca
Molineris, Ivan
Tamburrini, Annalaura
Meng, Guohua
Polignano, Isabelle Laurence
Scrivano, Mirko Giuseppe
Campestre, Fabiola
Simon, Lisa Marie
Rapelli, Stefania
Morandi, Edoardo
Incarnato, Danny
Oliviero, Salvatore
author_sort Maldotti, Mara
collection PubMed
description The histone acetyltransferase p300 (also known as KAT3B) is a general transcriptional coactivator that introduces the H3K27ac mark on enhancers triggering their activation and gene transcription. Genome-wide screenings demonstrated that a large fraction of long non-coding RNAs (lncRNAs) plays a role in cellular processes and organ development although the underlying molecular mechanisms remain largely unclear (1,2). We found 122 lncRNAs that interacts directly with p300. In depth analysis of one of these, lncSmad7, is required to maintain ESC self-renewal and it interacts to the C-terminal domain of p300. lncSmad7 also contains predicted RNA-DNA Hoogsteen forming base pairing. Combined Chromatin Isolation by RNA precipitation followed by sequencing (ChIRP-seq) together with CRISPR/Cas9 mutagenesis of the target sites demonstrate that lncSmad7 binds and recruits p300 to enhancers in trans, to trigger enhancer acetylation and transcriptional activation of its target genes. Thus, these results unveil a new mechanism by which p300 is recruited to the genome.
format Online
Article
Text
id pubmed-8934626
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-89346262022-03-21 The acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncSmad7 Maldotti, Mara Lauria, Andrea Anselmi, Francesca Molineris, Ivan Tamburrini, Annalaura Meng, Guohua Polignano, Isabelle Laurence Scrivano, Mirko Giuseppe Campestre, Fabiola Simon, Lisa Marie Rapelli, Stefania Morandi, Edoardo Incarnato, Danny Oliviero, Salvatore Nucleic Acids Res Gene regulation, Chromatin and Epigenetics The histone acetyltransferase p300 (also known as KAT3B) is a general transcriptional coactivator that introduces the H3K27ac mark on enhancers triggering their activation and gene transcription. Genome-wide screenings demonstrated that a large fraction of long non-coding RNAs (lncRNAs) plays a role in cellular processes and organ development although the underlying molecular mechanisms remain largely unclear (1,2). We found 122 lncRNAs that interacts directly with p300. In depth analysis of one of these, lncSmad7, is required to maintain ESC self-renewal and it interacts to the C-terminal domain of p300. lncSmad7 also contains predicted RNA-DNA Hoogsteen forming base pairing. Combined Chromatin Isolation by RNA precipitation followed by sequencing (ChIRP-seq) together with CRISPR/Cas9 mutagenesis of the target sites demonstrate that lncSmad7 binds and recruits p300 to enhancers in trans, to trigger enhancer acetylation and transcriptional activation of its target genes. Thus, these results unveil a new mechanism by which p300 is recruited to the genome. Oxford University Press 2022-02-07 /pmc/articles/PMC8934626/ /pubmed/35137201 http://dx.doi.org/10.1093/nar/gkac083 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Gene regulation, Chromatin and Epigenetics
Maldotti, Mara
Lauria, Andrea
Anselmi, Francesca
Molineris, Ivan
Tamburrini, Annalaura
Meng, Guohua
Polignano, Isabelle Laurence
Scrivano, Mirko Giuseppe
Campestre, Fabiola
Simon, Lisa Marie
Rapelli, Stefania
Morandi, Edoardo
Incarnato, Danny
Oliviero, Salvatore
The acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncSmad7
title The acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncSmad7
title_full The acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncSmad7
title_fullStr The acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncSmad7
title_full_unstemmed The acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncSmad7
title_short The acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncSmad7
title_sort acetyltransferase p300 is recruited in trans to multiple enhancer sites by lncsmad7
topic Gene regulation, Chromatin and Epigenetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934626/
https://www.ncbi.nlm.nih.gov/pubmed/35137201
http://dx.doi.org/10.1093/nar/gkac083
work_keys_str_mv AT maldottimara theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT lauriaandrea theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT anselmifrancesca theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT molinerisivan theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT tamburriniannalaura theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT mengguohua theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT polignanoisabellelaurence theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT scrivanomirkogiuseppe theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT campestrefabiola theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT simonlisamarie theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT rapellistefania theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT morandiedoardo theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT incarnatodanny theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT olivierosalvatore theacetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT maldottimara acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT lauriaandrea acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT anselmifrancesca acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT molinerisivan acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT tamburriniannalaura acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT mengguohua acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT polignanoisabellelaurence acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT scrivanomirkogiuseppe acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT campestrefabiola acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT simonlisamarie acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT rapellistefania acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT morandiedoardo acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT incarnatodanny acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7
AT olivierosalvatore acetyltransferasep300isrecruitedintranstomultipleenhancersitesbylncsmad7